Humacyte (HUMA) Earnings Date, Estimates & Call Transcripts → The Gold Grab of the Century (From Colonial Metals) (Ad) Free HUMA Stock Alerts $4.41 +0.01 (+0.23%) (As of 05/3/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 10EstimatedActual EPS (Mar. 22) -$0.24 Beat By $0.01 Consensus EPS (Mar. 22) -$0.25 Read Call TranscriptListen to CallLatest SEC 10-Q Filing Get Humacyte Earnings AlertsEnter your email address below to receive the latest news and earnings results for HUMA and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueHUMA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.HUMA Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. Humacyte Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.90) EPSNext Year EPS Consensus Estimate: ($0.66) EPSHUMA Earnings Date and InformationHumacyte last issued its quarterly earnings data on March 22nd, 2024. The reported ($0.24) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.25) by $0.01. Humacyte has generated ($1.07) earnings per share over the last year (($1.07) diluted earnings per share). Earnings for Humacyte are expected to grow in the coming year, from ($0.90) to ($0.66) per share. Humacyte has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 10th, 2024 based off prior year's report dates.Read More Humacyte Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/10/2024Estimated)------- 3/22/2024Q4 2023($0.25)($0.24)+$0.01($0.24)$0.10 million- 11/9/2023Q3 2023($0.25)($0.25)-($0.25)--8/14/2023Q2 2023($0.22)($0.22)-($0.22)$0.10 million- 5/12/2023Q1 2023($0.22)($0.22)-($0.08)--3/24/2023Q4 2022($0.24)($0.21)+$0.03($0.38)--11/10/2022Q3 2022($0.21)($0.25)($0.04)($0.25)$0.26 million$0.03 million Get the Latest News and Ratings for HUMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Humacyte and its competitors with MarketBeat's FREE daily newsletter. 8/12/2022Q2 2022($0.22)($0.19)+$0.03($0.73)$0.27 million$1.30 million5/13/2022Q1 2022($0.21)($0.22)($0.01)($0.25)$0.27 million$0.23 million 3/29/2022Q4 2021($0.19)($0.22)($0.03)($0.85)$0.26 million$0.18 million 11/12/2021Q3 2021($0.20)($0.50)($0.30)($0.28)$0.27 million$0.24 million Humacyte Earnings - Frequently Asked Questions When is Humacyte's earnings date? Humacyte has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 10th, 2024 based off last year's report dates. Learn more on HUMA's earnings history. Did Humacyte beat their earnings estimates last quarter? In the previous quarter, Humacyte (NASDAQ:HUMA) reported ($0.24) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.25) by $0.01. Learn more on analysts' earnings estimate vs. HUMA's actual earnings. How can I listen to Humacyte's earnings conference call? The conference call for Humacyte's latest earnings report can be listened to online. Listen to Conference Call How can I read Humacyte's conference call transcript? The conference call transcript for Humacyte's latest earnings report can be read online. Read Transcript How can I view Humacyte's earnings report? Humacyte's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Humacyte generate each year? Humacyte (NASDAQ:HUMA) has a recorded annual revenue of $1.57 million. How much profit does Humacyte generate each year? Humacyte (NASDAQ:HUMA) has a recorded net income of -$110.78 million. HUMA has generated -$1.07 earnings per share over the last four quarters. What is Humacyte's EPS forecast for next year? Humacyte's earnings are expected to grow from ($0.90) per share to ($0.66) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Taysha Gene Therapies Earnings C4 Therapeutics Earnings Editas Medicine Earnings Alector Earnings Fate Therapeutics Earnings Alvotech Earnings Voyager Therapeutics Earnings Exscientia Earnings Lexeo Therapeutics Earnings Valneva Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Apple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings? This page (NASDAQ:HUMA) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldInvestors Alert: The Next Big Thing in Weight LossBehind the MarketsStock-Picking AI Predicts #1 Stock of 2024AltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithGlobal crypto currency reset (41 major banks signed up)Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Humacyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
